retatrutide expanded access program New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Eli Lilly to offer retatrutide

What Makes Our Treatment Different

Quicker weight loss can backfire by lowering the rate at which your body burns calories, promoting muscle loss and possibly leaving you deficient in certain key nutrients

Panksepp J

FDA Approval and Regulatory Oversight The FDA plays a critical role in approving medications like Semaglutide and monitoring their safety post-approval through the assessment of adverse event reports

Improving Insulin Sensitivity: Both medications help regulate blood sugar levels, reducing hunger and food cravings

48 Given the structural absence of GLP-1R identified in human liver tissue, this appears to be a compromise